Literature DB >> 16434372

An electronic tool for venous thromboembolism prevention in medical and surgical patients.

Meyer-Michel Samama1, Ola E Dahl, Patrick Mismetti, Daniel J Quinlan, Nadia Rosencher, Marleen Cornelis, Han de Vries, Ineke van Beusekom, James P Kahan.   

Abstract

BACKGROUND AND OBJECTIVES: Venous thromboembolism (VTE) is a complex disorder influenced by numerous risk factors, and occurs frequently in at-risk hospitalized patients. Because appropriate prevention with thromboprophylaxis is underused, we wanted to create an electronic tool to provide a simple risk assessment and suggest appropriate prophylaxis. DESIGN AND METHODS: To develop the risk matrix, iterative rating of odds ratios was performed for 60 predisposing VTE risk factors, using analytical methods that account for multiple risk factors in a single patient and their non-independence. For exposing risk factors, a single score was assigned to each set of factors, both medical (25 items) and surgical conditions (144 items). A CART regression model was used to integrate the risk scales into a 4-level measure of overall risk. The validity of the level of risk and the appropriateness of 11 different prophylactic approaches was assessed using the RAND/UCLA appropriateness method and validated by expert opinion ratings (n=1998) on sample case scenarios (n=108).
RESULTS: Correlation between the level of risk calculated by the risk matrix and that offered by expert opinion for individual surgical and medical clinical cases was high (65% and 70%, respectively). The matrix over-estimated the level of risk, compared with that offered by expert opinion, in 28% and 20% of surgical and medical cases, respectively, but the appropriate prophylaxis suggested was no different. Between-expert agreement on the appropriateness of the prophylaxis recommendations was high (90-94% of indications). INTERPRETATION AND
CONCLUSIONS: This computer-based electronic tool for individualized assessment of venous thromboembolic risk successfully identified both the perceived risk of thrombosis and the appropriate prophylactic approach for medical and surgical patients.

Entities:  

Mesh:

Year:  2006        PMID: 16434372

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  12 in total

Review 1.  Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review.

Authors:  Wei Huang; Frederick A Anderson; Frederick A Spencer; Alexander Gallus; Robert J Goldberg
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

Review 2.  The clinical significance of coagulation and the inflammatory response in autoimmunity.

Authors:  Benjamín Rubio-Jurado; Paulina Iñiguez-Franco; Pedro A Reyes; Gustavo Robles; Mario Salazar-Páramo; Guadalupe Zavala-Cerna; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

3.  Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews.

Authors:  Andrea J Darzi; Allen B Repp; Frederick A Spencer; Rami Z Morsi; Rana Charide; Itziar Etxeandia-Ikobaltzeta; Kenneth A Bauer; Allison E Burnett; Mary Cushman; Francesco Dentali; Susan R Kahn; Suely M Rezende; Neil A Zakai; Arnav Agarwal; Samer G Karam; Tamara Lotfi; Wojtek Wiercioch; Reem Waziry; Alfonso Iorio; Elie A Akl; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-10-13

4.  Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer.

Authors:  M Chavez-MacGregor; H Zhao; M Kroll; S Fang; N Zhang; G N Hortobagyi; T A Buchholz; Y-C Shih; S H Giordano
Journal:  Ann Oncol       Date:  2011-03-10       Impact factor: 32.976

5.  Antithrombotic prophylaxis in the middle East.

Authors:  Samir Arnaout; Hanady R Samaha; Julien Succar; Imad Bou-Akl; Khaled M Musallam; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-24       Impact factor: 2.576

6.  An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients.

Authors:  Meyer Michel Samama; Franz-Xaver Kleber
Journal:  Thromb J       Date:  2006-07-03

7.  Thrombotic risk assessment questionary helps increase the use of thromboprophylaxis for patients with pelvic and acetabular fractures.

Authors:  Haili Wang; Wei Chen; Yanling Su; Zhiyong Li; Ming Li; Zhanpo Wu; Yingze Zhang
Journal:  Indian J Orthop       Date:  2012-07       Impact factor: 1.251

8.  Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.

Authors:  Paolo Prandoni
Journal:  Thromb J       Date:  2008-09-09

Review 9.  Primary prevention of venous thromboembolism in elderly medical patients.

Authors:  Karine Lacut; Gregoire Le Gal; Dominique Mottier
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

Review 10.  Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes.

Authors:  Aristoteles Giagounidis; Pierre Fenaux; Ghulam J Mufti; Petra Muus; Uwe Platzbecker; Guillermo Sanz; Larry Cripe; Marie Von Lilienfeld-Toal; Richard A Wells
Journal:  Ann Hematol       Date:  2008-02-12       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.